Silver Book

Silver Book Fact

A statin initiation intervention aimed at Medicare Part D prescription drug plan subscribers with diabetes or coronary artery disease was successful in increasing statin use among this group of members at high risk for cardiovascular events. The estimated coronary event cost avoidance was $12,323 per 220 members who received the intervention.

Stockl, Karen M., Daniel Tjioe, Sherry Gong, Jenni Stroup, Ann S.M. Harada, and Heidi C. Lew. Effect of an Intervention to Increase Statin Use in Medicare Members Who Qualified for a Medication Therapy Management Program. J Manag Care Pharm. 2008; 14(6): 532-40. http://www.amcp.org/data/jmcp/JMCPMaga_532-540.pdf

Reference

Title
Effect of an Intervention to Increase Statin Use in Medicare Members Who Qualified for a Medication Therapy Management Program
Publication
J Manag Care Pharm
Publication Date
2008
Authors
Stockl, Karen M., Daniel Tjioe, Sherry Gong, Jenni Stroup, Ann S.M. Harada, and Heidi C. Lew
Volume & Issue
Volume 14, Issue 6
Pages
532-40
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • Remote Interpretation of Retinal Imaging for DR
    Use of remote interpretation of retinal imaging in diabetics sent via tele-ophthalmology, improved the frequency of screening from 32% to 71% in only 12 months.  
  • 150 drugs are in development for diabetes. Diabetes affects 12.2 million Americans age 60 and older.  
  • Economics of DR Treatment
    Laser treatment plus a VEGF inhibitor achieved an incremental cost-effectiveness ratio of $12,410 per quality adjusted life year in patients with DME.  
  • Therapy that keeps blood glucose levels as close to normal as possible in type 1 diabetics, reduces damage to the kidneys by 35-56%. Experts believe that these results can be…  
  • Detecting and treating diabetic eye disease with laser therapy can reduce the development of severe vision loss by an estimated 50% to 60%.